Related Experiment Videos
Selective lymphocyte deficiency in seronegative rheumatoid arthritis
Arthritis and Rheumatism
|June 1, 1981
Summary
Epstein Barr virus (EBV) infection induces less IgM rheumatoid factor in seronegative rheumatoid arthritis patients. This suggests a deficiency in Epstein Barr virus-responsive B cells in these patients.
Area of Science:
- Immunology
- Virology
- Rheumatology
Background:
- Epstein Barr virus (EBV) is known to induce IgM rheumatoid factor (RF) production in vitro.
- Seropositive rheumatoid arthritis lymphocytes show higher EBV-induced IgM RF production compared to normal lymphocytes.
Purpose of the Study:
- To investigate the in vitro IgM rheumatoid factor production by Epstein Barr virus-infected lymphocytes from seronegative rheumatoid arthritis patients.
- To determine if seronegative rheumatoid arthritis patients have a deficiency in Epstein Barr virus-responsive B cells.
Main Methods:
- In vitro infection of lymphocytes with Epstein Barr virus.
- Quantification of IgM rheumatoid factor production.
Main Results:
- Lymphocytes from seronegative rheumatoid arthritis patients produced significantly less IgM rheumatoid factor after EBV infection compared to normal lymphocytes.
- This indicates a reduced capacity for IgM RF generation in response to EBV in this patient group.
Conclusions:
- Peripheral blood of seronegative rheumatoid arthritis patients may be deficient in Epstein Barr virus-responsive rheumatoid factor precursor B cells.
- This deficiency could contribute to the pathogenesis of seronegative rheumatoid arthritis.